Market Mover: Tempest (TPST) Rises at Midday August 4

Equities Staff  |

Shares of Tempest Therapeutics Inc (NASDAQ: TPST) rose 10.43% Thursday.

As of 11:59:30 est, Tempest is currently sitting at $2.33 and has risen $0.22 so far today.

Tempest has moved 7.86% over the last 30 days and has a YTD change of 60.04% based on the most recent close.

The company expects its next earnings on 2022-08-11.

For technical charts, analysis, and more on Tempest visit the company profile.

About Tempest Therapeutics Inc

Millendo Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.

To get more information on Tempest Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Tempest Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

testforhref
The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content